GenePlus
Medical AI · Molecular Diagnostics
Overview
GenePlus is a Chinese precision medicine company that uses an AI-driven multi-omics platform for biomarker and target discovery, diagnostics and drug development support. It develops oncology NGS products, including methylation-based tests, and works with leading hospitals in China. The company is headquartered in Beijing, China.
Funding and backers
Total raised
$42M
1 round on record
Latest round
$42M
Series D · Dec 2025 · 11 mo ago
Team
201-500
employees, estimated range
Hiring now
1
open roles
The money's age
Fresh money
11 months since the last round · hiring slowed
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | Dec 2025 | $42M | — | 投资界 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Geneseeq is a Chinese precision oncology company applying high-throughput sequencing to clinical genetic testing for cancer patients. Its…
AI-powered biomarker assays using multi-omics and mass spectrometry to accelerate diagnostics, drug development, and precision medicine for…
Mindpeak transforms tissue into high-dimensional data, enabling the discovery of AI-driven biomarkers that guide targeted therapies and…
Bringing Precision Medicine to the Animal Health.
Genomics plc is an Oxford company founded in 2014 by statistical geneticists to turn genomic data into health insight. Its integrated risk…
Baylor Genetics specializes in clinically relevant genetic testing and helps determine an individual’s chance of developing or passing on a…
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
100% ▼
Financials
Total raised
$42M
Latest round
Series D
Funding rounds
1
Investors
7
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series D | 2025 | $42M | Details |
Key Investors
宁波梅山保税港区博源卓星投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
深圳市松禾国创新能股权投资基金合伙企业（有限合伙）
shareholder on the register (清科 zdb)
深圳市松禾成长一号股权投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
深圳成潍新生命投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
上海火山石一期股权投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
北京吉因家股权投资企业（有限合伙）
shareholder on the register (清科 zdb)
深圳吉因加投资有限公司
shareholder on the register (清科 zdb)
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Beijing